Selected literature.
- Published in:
- 2010
- Publication type:
- Journal Article
Works matching IS 1082801X AND DT 2010 AND VI 45 AND IP 1
Results: 24
1
2
News capsules. Dabigatran compared to warfarin when given to patients with atrial fibrillation.
- Published in:
- 2010
- Publication type:
- Journal Article
3
New molecular entity. Folotyn.
- Published in:
- 2010
- Publication type:
- Journal Article
4
Erectile dysfunction and premature ejaculation: underlying causes and available treatments.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
5
Medication safety and reliability. FDA's Safe Use Initiative to address preventable harm due to medication misuse, errors, and other related problems.
- Published in:
- 2010
- Publication type:
- Journal Article
6
New formulation. Pennsaid.
- Published in:
- 2010
- Publication type:
- Journal Article
7
News capsules. Researchers seek prescription patterns and predictors of use of aldosterone antagonists in patients with HF.
- Published in:
- 2010
- Publication type:
- Journal Article
8
Medication safety and reliability. Exenatide drug label to include information on post-marketing surveillance of altered kidney function.
- Published in:
- 2010
- Publication type:
- Journal Article
9
FDA's Safe Use Initiative to address preventable harm due to medication misuse, errors, and other related problems.
- Published in:
- Formulary, 2010, v. 45, n. 1, p. 29
- Publication type:
- Article
10
News capsules. ACE inhibitors versus ARBs for ischemic heart disease: comparative effectiveness.
- Published in:
- 2010
- Publication type:
- Journal Article
11
Anticoagulants and antiplatelet agents.
- Published in:
- Formulary, 2010, v. 45, n. 1, p. 32
- Publication type:
- Article
12
Selected literature.
- Published in:
- 2010
- Publication type:
- Bibliography
13
Drug pricing, safety, access to dominate agenda in the year ahead.
- Published in:
- Formulary, 2010, v. 45, n. 1, p. 30
- By:
- Publication type:
- Article
14
Roflumilast: a new phosphodiesterase 4 inhibitor for chronic obstructive pulmonary disease.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
15
Exenatide drug label to include information on post-marketing surveillance of altered kidney function.
- Published in:
- Formulary, 2010, v. 45, n. 1, p. 28
- Publication type:
- Article
16
Erectile dysfunction and premature ejaculation: underlying causes and available treatments.
- Published in:
- Formulary, 2010, v. 45, n. 1, p. 17
- By:
- Publication type:
- Article
17
Dabigatran compared to warfarin when given to patients with atrial fibrillation.
- Published in:
- Formulary, 2010, v. 45, n. 1, p. 16
- Publication type:
- Article
18
ACE inhibitors versus ARBs for ischemic heart disease: comparative effectiveness.
- Published in:
- Formulary, 2010, v. 45, n. 1, p. 15
- Publication type:
- Article
19
Researchers seek prescription patterns and predictors of use of aldosterone antagonists in patients with HF.
- Published in:
- Formulary, 2010, v. 45, n. 1, p. 14
- Publication type:
- Article
20
Roflumilast: A new phosphodiesterase 4 inhibitor for chronic obstructive pulmonary disease.
- Published in:
- Formulary, 2010, v. 45, n. 1, p. 6
- By:
- Publication type:
- Article
21
FDA actions in brief.
- Published in:
- Formulary, 2010, v. 45, n. 1, p. 5
- Publication type:
- Article
22
Folotyn.
- Published in:
- Formulary, 2010, v. 45, n. 1, p. 4
- Publication type:
- Article
23
Pennsaid.
- Published in:
- Formulary, 2010, v. 45, n. 1, p. 4
- Publication type:
- Article
24
Pipeline preview.
- Published in:
- Formulary, 2010, v. 45, n. 1, p. 4
- Publication type:
- Article